HHLR Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

HHLR Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-690,658	Closed	-$94.2M	–	108
2020 Q3	$94.2M	Hold	690,658	–	–	0.71%	24
2020 Q2	$66.7M	Sell	690,658 -285,329	-29%	-$23.8M	0.61%	26
2020 Q1	$45.8M	Hold	975,987	–	–	0.62%	27
2019 Q4	$71.1M	Hold	975,987	–	–	0.89%	23
2019 Q3	$50.9M	Hold	975,987	–	–	0.7%	25
2019 Q2	$48.9M	Hold	975,987	–	–	1.09%	22
2019 Q1	$50.7M	Buy	975,987 +117,647	+14%	+$5.42M	1.41%	16
2018 Q4	$41.9M	Buy	+858,340	New	+$47.2M	1.74%	11

HHLR Advisors's MYOK Position: Q4 2020 in Review

HHLR Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 690,658 shares — an estimated $94.2M sold.

HHLR Advisors first reported a position in MYOK in Q4 2018 and held it in 8 quarters. The position peaked at $94.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

HHLR Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
HHLR Advisors sold 690,658 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $94.2M.
HHLR Advisors first reported a position in MyoKardia, Inc. Common Stock in Q4 2018 and held it in 8 quarters.
HHLR Advisors's MyoKardia, Inc. Common Stock position peaked at $94.2M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on HHLR Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.